How SARS-CoV-2 Infection Impacts the Management of Patients with Vulvar Cancer: Experience in a Third-Level Hospital of Southern Italy
<b>Background:</b> Since February 2020, the spread of Coronavirus Disease 2019 (COVID-19) in Italy has induced the government to call for lockdown of any activity apart from primary needs, and changing the lives of each of us. All that has dramatically impacted the management of patients...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/13/2/240 |
_version_ | 1797619941801721856 |
---|---|
author | Luigi Della Corte Valeria Cafasso Dominga Boccia Ilaria Morra Carmine De Angelis Sabino De Placido Pierluigi Giampaolino Costantino Di Carlo Giuseppe Bifulco |
author_facet | Luigi Della Corte Valeria Cafasso Dominga Boccia Ilaria Morra Carmine De Angelis Sabino De Placido Pierluigi Giampaolino Costantino Di Carlo Giuseppe Bifulco |
author_sort | Luigi Della Corte |
collection | DOAJ |
description | <b>Background:</b> Since February 2020, the spread of Coronavirus Disease 2019 (COVID-19) in Italy has induced the government to call for lockdown of any activity apart from primary needs, and changing the lives of each of us. All that has dramatically impacted the management of patients affected by cancer. Patients with vulvar cancer (VC) represent a particularly frail population because they are elderly and affected by multiple comorbidities. The aim of this study is to evaluate the clinical impact of the SARS-CoV-2 infection on VC patients in terms of delay or impossibility of carrying out the scheduled treatment. <b>Methods:</b> The medical records of patients affected by vulvar tumors, referred to “DAI Materno-Infantile” of AOU Federico II of Naples between February 2020 and January 2022 were retrospectively analyzed. The presence of a positive reverse transcription-polymerase chain reaction (RT-PCR) in nasopharyngeal swab defined the positivity to SARS-CoV-2. <b>Results:</b> Twenty-four patients with VC were analyzed and scheduled for treatment. The median age was 70.7 years (range: 59–80). Seven (29.2%) patients were diagnosed with SARS-CoV-2 infection: In three (42.8%) patients, the treatment was delayed with no apparent consequences, in four (57.2%), the treatment was delayed or changed due to cancer progression and, of these four, one died due to respiratory complications of COVID-19, and one died due to oncologic disease progression. <b>Conclusion:</b> COVID-19 caused, in most cases, significant delays in oncologic treatments and high mortality in our series of patients affected by VC. |
first_indexed | 2024-03-11T08:34:11Z |
format | Article |
id | doaj.art-05f074ebc27e43f3b9d175d7f3c48f18 |
institution | Directory Open Access Journal |
issn | 2075-4426 |
language | English |
last_indexed | 2024-03-11T08:34:11Z |
publishDate | 2023-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Personalized Medicine |
spelling | doaj.art-05f074ebc27e43f3b9d175d7f3c48f182023-11-16T21:32:40ZengMDPI AGJournal of Personalized Medicine2075-44262023-01-0113224010.3390/jpm13020240How SARS-CoV-2 Infection Impacts the Management of Patients with Vulvar Cancer: Experience in a Third-Level Hospital of Southern ItalyLuigi Della Corte0Valeria Cafasso1Dominga Boccia2Ilaria Morra3Carmine De Angelis4Sabino De Placido5Pierluigi Giampaolino6Costantino Di Carlo7Giuseppe Bifulco8Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, 84014 Naples, ItalyDepartment of Public Health, School of Medicine, University of Naples Federico II, 84014 Napoli, ItalyDepartment of Public Health, School of Medicine, University of Naples Federico II, 84014 Napoli, ItalyDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, 84014 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 84014 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 84014 Naples, ItalyDepartment of Public Health, School of Medicine, University of Naples Federico II, 84014 Napoli, ItalyDepartment of Public Health, School of Medicine, University of Naples Federico II, 84014 Napoli, ItalyDepartment of Public Health, School of Medicine, University of Naples Federico II, 84014 Napoli, Italy<b>Background:</b> Since February 2020, the spread of Coronavirus Disease 2019 (COVID-19) in Italy has induced the government to call for lockdown of any activity apart from primary needs, and changing the lives of each of us. All that has dramatically impacted the management of patients affected by cancer. Patients with vulvar cancer (VC) represent a particularly frail population because they are elderly and affected by multiple comorbidities. The aim of this study is to evaluate the clinical impact of the SARS-CoV-2 infection on VC patients in terms of delay or impossibility of carrying out the scheduled treatment. <b>Methods:</b> The medical records of patients affected by vulvar tumors, referred to “DAI Materno-Infantile” of AOU Federico II of Naples between February 2020 and January 2022 were retrospectively analyzed. The presence of a positive reverse transcription-polymerase chain reaction (RT-PCR) in nasopharyngeal swab defined the positivity to SARS-CoV-2. <b>Results:</b> Twenty-four patients with VC were analyzed and scheduled for treatment. The median age was 70.7 years (range: 59–80). Seven (29.2%) patients were diagnosed with SARS-CoV-2 infection: In three (42.8%) patients, the treatment was delayed with no apparent consequences, in four (57.2%), the treatment was delayed or changed due to cancer progression and, of these four, one died due to respiratory complications of COVID-19, and one died due to oncologic disease progression. <b>Conclusion:</b> COVID-19 caused, in most cases, significant delays in oncologic treatments and high mortality in our series of patients affected by VC.https://www.mdpi.com/2075-4426/13/2/240vulvar cancerCOVID-19management |
spellingShingle | Luigi Della Corte Valeria Cafasso Dominga Boccia Ilaria Morra Carmine De Angelis Sabino De Placido Pierluigi Giampaolino Costantino Di Carlo Giuseppe Bifulco How SARS-CoV-2 Infection Impacts the Management of Patients with Vulvar Cancer: Experience in a Third-Level Hospital of Southern Italy Journal of Personalized Medicine vulvar cancer COVID-19 management |
title | How SARS-CoV-2 Infection Impacts the Management of Patients with Vulvar Cancer: Experience in a Third-Level Hospital of Southern Italy |
title_full | How SARS-CoV-2 Infection Impacts the Management of Patients with Vulvar Cancer: Experience in a Third-Level Hospital of Southern Italy |
title_fullStr | How SARS-CoV-2 Infection Impacts the Management of Patients with Vulvar Cancer: Experience in a Third-Level Hospital of Southern Italy |
title_full_unstemmed | How SARS-CoV-2 Infection Impacts the Management of Patients with Vulvar Cancer: Experience in a Third-Level Hospital of Southern Italy |
title_short | How SARS-CoV-2 Infection Impacts the Management of Patients with Vulvar Cancer: Experience in a Third-Level Hospital of Southern Italy |
title_sort | how sars cov 2 infection impacts the management of patients with vulvar cancer experience in a third level hospital of southern italy |
topic | vulvar cancer COVID-19 management |
url | https://www.mdpi.com/2075-4426/13/2/240 |
work_keys_str_mv | AT luigidellacorte howsarscov2infectionimpactsthemanagementofpatientswithvulvarcancerexperienceinathirdlevelhospitalofsouthernitaly AT valeriacafasso howsarscov2infectionimpactsthemanagementofpatientswithvulvarcancerexperienceinathirdlevelhospitalofsouthernitaly AT domingaboccia howsarscov2infectionimpactsthemanagementofpatientswithvulvarcancerexperienceinathirdlevelhospitalofsouthernitaly AT ilariamorra howsarscov2infectionimpactsthemanagementofpatientswithvulvarcancerexperienceinathirdlevelhospitalofsouthernitaly AT carminedeangelis howsarscov2infectionimpactsthemanagementofpatientswithvulvarcancerexperienceinathirdlevelhospitalofsouthernitaly AT sabinodeplacido howsarscov2infectionimpactsthemanagementofpatientswithvulvarcancerexperienceinathirdlevelhospitalofsouthernitaly AT pierluigigiampaolino howsarscov2infectionimpactsthemanagementofpatientswithvulvarcancerexperienceinathirdlevelhospitalofsouthernitaly AT costantinodicarlo howsarscov2infectionimpactsthemanagementofpatientswithvulvarcancerexperienceinathirdlevelhospitalofsouthernitaly AT giuseppebifulco howsarscov2infectionimpactsthemanagementofpatientswithvulvarcancerexperienceinathirdlevelhospitalofsouthernitaly |